openPR Logo
Press release

Drug Delivery Market 2018 | Johnson, Bayer

Report Summary

The Global Drug Delivery Market Size is primarily driven by the increasing demand for technological advanced products that are used for drug delivery, and increased number of chronic diseases in the increasing number of geriatric population.

Drug delivery is referred as drug administration in the human body through injections or various other devices. Drug delivery devices are used to inject the therapeutic substances in the body with the help of various routes. These routes of administration depend on the type of disease that a patient suffers, and nature of the drug that is available. Drugs help in improving and extending once life by properly diagnosing the disease. Recently, drug delivery includes the targeted delivery which specially focuses on the target area of the body. In order to achieve efficiency, the targeted drugs act effectively work without creating any side effects to other body parts.

Request for sample copy of this report @
https://www.polarismarketresearch.com/industry-analysis/global-drug-delivery-market/request-for-free-sample

Drug delivery devices also play an important role as they are conventional and implantable. The devices not only help the efficiency but also enhance the accuracy for drug delivery. For instance, the device can help in accurately administrating the drugs like insulin, the devices used are infusion catheters namely valves, set, needles, cannulas and many more. Transcellular and paracellular are most commonly used routes for drug administration. The practice for drug delivery has changed in past few decades that is creating a good pace for the new and existing manufacturers in the near future.

Rising number of technologically advanced products that are used for drug delivery and rising number of chronic diseases globally to boost the drug delivery market.
The drug delivery market is basically driven by the rising prevalence of chronic disease, and increased number of clinical trials that focus on the biologics drugs in the market. Similarly, the rising technological advancements and continuous new product development would also influence the market growth. Moreover, increased government focus on improving the efficiency and safety of drugs will drive the market significantly in the coming years.

Browse Complete Summary of this report @ https://www.polarismarketresearch.com/industry-analysis/global-drug-delivery-market/

Global Drug Delivery Market Taxonomy
The global drug delivery market size is segmented on the basis of route of administration, product, end use and geography.
On the basis of route of administration, the global drug delivery market size is segmented as:
• Oral Drug Delivery
• Skin Drug Delivery
• Ophthalmic Drug Delivery
• Rectal Drug Delivery
• Vaginal Drug Delivery
• Nasal Drug Delivery

On the basis of product development, the global drug delivery market share is segmented as:
• Device
• Transdermal Gel
• Transdermal Patches
• Formulation
• Solid Topical Formulation
• Liquid Topical Formulation
• Semi-Solid Topical Formulation

On the basis of end use, the global drug delivery market size is segmented as:
• Hospitals
• Private Clinics
• Home Care Setting
• Pharmacy Store
• Others

About us Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Market 2018 | Johnson, Bayer here

News-ID: 1351456 • Views:

More Releases from Polaris Market Research & Consulting

Beta-Glucan Market is anticipated to grow from USD 666.60 million in 2024 to USD 1262.91 million by 2032
Beta-Glucan Market is anticipated to grow from USD 666.60 million in 2024 to USD …
The global beta-glucan market is expected to reach USD 1262.91 million by 2032, growing at an 8.3% CAGR from 2024 to 2032. It was valued at USD 615.68 million in 2023. The market is experiencing significant growth and is expected to continue expanding in the coming years. Beta-glucans are dissolvable fibers that emanate from the cell walls of bacteria, yeast, fungi, and some plants. They are helpful in lessening the probability
Methanol Market is anticipated to grow from US$ 32.47 billion in 2024 to US$ 47.21 billion by 2032, at a CAGR of 4.8% from 2024 to 2032 | PMR
Methanol Market is anticipated to grow from US$ 32.47 billion in 2024 to US$ 47. …
The increased production of other basic chemicals used in end-use products and fuels is the primary factor driving the growth of the industry. Besides, the advent of new applications of methanol, which include fuel blending, ether production, and light olefins, is supporting the expansion of the market. 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐞𝐭𝐡𝐚𝐧𝐨𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟑𝟏.𝟎𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 𝟒𝟕.𝟐𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧
Hydrogen Peroxide Market Predicted to Grow at 4.8% CAGR, Reaching USD 5145.43 Million by 2032 | Data by PMR
Hydrogen Peroxide Market Predicted to Grow at 4.8% CAGR, Reaching USD 5145.43 Mi …
According to Polaris Market Research's study, the hydrogen peroxide market is expected to grow at a CAGR of 4.8% over the estimated period. The industry value is expected to grow from USD 3380.00 million in 2023 to USD 5145.43 million in 2032. The industry's growth is being fuelled by its discharge-free and sustainable attributes. Thus, customers growingly opt for to utilize chemicals for several contamination regulation and water ministration solicitation. 𝐀𝐜𝐜𝐞𝐬𝐬
Printing Inks Market is anticipated to grow from USD 22.19 billion in 2024 to USD 39.66 billion by 2032
Printing Inks Market is anticipated to grow from USD 22.19 billion in 2024 to US …
The global printing inks market was valued at USD 20.65 billion in 2023 and is expected to grow to USD 39.66 billion by 2032. The market is expected to expand at a CAGR of 7.5% during the forecast period from 2024 to 2032. Various factors propelling the demand for the printing ink industry include: The printing ink industry has witnessed significant growth, particularly in the flexible packaging segment, over the past

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug